News
Boehringer, Lilly hail Jardiance data in hard-to-treat heart...
Boehringer Ingelheim and Eli Lilly have the results they were hoping for in a large-scale study of Jardiance therapy in heart failure with preserved ejection fraction (HFpEF), a form of chr
